These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 17054609)
1. Screening asymptomatic patients with type 2 diabetes: The debates persist. Beller GA; Bourque JM J Nucl Cardiol; 2015 Dec; 22(6):1233-6. PubMed ID: 26391501 [No Abstract] [Full Text] [Related]
2. Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study. Dehpouri T; Rokni GR; Narenjbon NA; Goldust M; Yamauchi PS; Wollina U; Lotti T; Kircik L; Lernia VGD; Sonthalia S; Vojvodic A; Szepietowski J; Bahadoran P; Errichetti E; Cantisani C; Atzori L; Rezaee E; Kutlubay Z; Engin B; Nisticò S; Damiani G; Conic RRZ; Goren A; Čabrijan L; Tchernev G Dermatol Reports; 2019 Jan; 11(1):7965. PubMed ID: 31210916 [TBL] [Abstract][Full Text] [Related]
3. Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Brown TM; Voeks JH; Bittner V; Safford MM Am Heart J; 2010 Mar; 159(3):385-91. PubMed ID: 20211299 [TBL] [Abstract][Full Text] [Related]
4. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE; Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172 [TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes. Fukui M; Ose H; Kitagawa Y; Kamiuchi K; Nakayama I; Ohta M; Obayashi H; Yamasaki M; Hasegawa G; Yoshikawa T; Nakamura N Diabet Med; 2007 Aug; 24(8):864-71. PubMed ID: 17593243 [TBL] [Abstract][Full Text] [Related]
7. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468 [TBL] [Abstract][Full Text] [Related]
8. The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in Type 2 diabetic patients. The Valpolicella Heart Diabetes Study. Targher G; Bertolini L; Tessari R; Zenari L; Arcaro G Diabet Med; 2006 Nov; 23(11):1270-1. PubMed ID: 17054609 [No Abstract] [Full Text] [Related]
9. The metabolic syndrome and risk of cardiovascular disease and diabetes: experiences with the new diagnostic criteria from the International Diabetes Federation. Saely CH; Rein P; Drexel H Horm Metab Res; 2007 Sep; 39(9):642-50. PubMed ID: 17846971 [TBL] [Abstract][Full Text] [Related]
10. [Do we recognize type-II diabetes in timely fashion?]. Hauner H Dtsch Med Wochenschr; 1992 May; 117(21):835-40. PubMed ID: 1587218 [No Abstract] [Full Text] [Related]
11. Diabetes--asking the right questions. Hyman MA Altern Ther Health Med; 2006; 12(5):10-3. PubMed ID: 17017750 [No Abstract] [Full Text] [Related]